StockData
AVITA Medical, Inc. logo

AVITA Medical, Inc. (RCEL) stock

RCELNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as AVHHL
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30
$16.20−1.10 (-6.36%)

Close on Nov 12, 2026Market cap $501.02MP/E –Yield –

AVITA Medical ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

AVITA Medical's ebitda for the twelve months ending Sep 30, 2026 was -$26.17M. For fiscal 2025 it was -$40.19M. The highest annual figure on record is -$13.73M in fiscal 2018.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$40.19M–
FY2024Dec 31, 2024-$55.47M–
FY2023Dec 31, 2023-$42.02M–
FY2021Jun 30, 2021-$25.83M–
FY2020Jun 30, 2020-$42.21M–
FY2019Jun 30, 2019-$25.26M–
FY2018Jun 30, 2018-$13.73M–

Quarterly ebitda

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ3 2026Sep 30, 2026-$2.04M–
Q2 FY2026CQ2 2026Jun 30, 2026-$6.25M–
Q1 FY2026CQ1 2026Mar 31, 2026-$8.18M–
Q4 FY2025CQ4 2025Dec 31, 2025-$9.71M–
Q3 FY2025CQ3 2025Sep 30, 2025-$8.58M–
Q2 FY2025CQ2 2025Jun 30, 2025-$10.60M–
Q1 FY2025CQ1 2025Mar 31, 2025-$11.31M–
Q4 FY2024CQ4 2024Dec 31, 2024-$9.55M–
Q3 FY2024CQ3 2024Sep 30, 2024-$13.50M–
Q2 FY2024CQ2 2024Jun 30, 2024-$15.42M–
Q1 FY2024CQ1 2024Mar 31, 2024-$17.00M–
Q4 FY2023CQ4 2023Dec 31, 2023-$12.09M–
Q3 FY2023CQ3 2023Sep 30, 2023-$9.14M–
Q2 FY2023CQ2 2023Jun 30, 2023-$11.02M–
Q1 FY2023CQ1 2023Mar 31, 2023-$9.78M–
Q4 FY2021CQ2 2021Jun 30, 2021-$4.53M–
Q3 FY2021CQ1 2021Mar 31, 2021-$5.82M–
Q2 FY2021CQ4 2020Dec 31, 2020-$5.47M–
Q1 FY2021CQ3 2020Sep 30, 2020-$10.00M–
Q4 FY2020CQ2 2020Jun 30, 2020-$12.81M–
Q3 FY2020CQ1 2020Mar 31, 2020-$15.32M–
Q2 FY2020CQ4 2019Dec 31, 2019-$10.49M–
Q1 FY2020CQ3 2019Sep 30, 2019-$3.59M–

More AVITA Medical figures

See a number that looks wrong?